CN103860905A - Traditional Chinese medicine preparation for treating osteoporosis - Google Patents
Traditional Chinese medicine preparation for treating osteoporosis Download PDFInfo
- Publication number
- CN103860905A CN103860905A CN201410106278.7A CN201410106278A CN103860905A CN 103860905 A CN103860905 A CN 103860905A CN 201410106278 A CN201410106278 A CN 201410106278A CN 103860905 A CN103860905 A CN 103860905A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- medicine preparation
- traditional chinese
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention discloses a traditional Chinese medicine preparation for treating osteoporosis. Traditional Chinese medicine believes that kidney governing bones and produced marrow stored in essence are congenital foundation. If kidney essence is sufficient, marrow has biochemical sources; if kidney essence is insufficient, marrow is biochemically insufficient; a medullary space is empty to cause that skeletons cannot be nourished, resulting in skeletal dysplasia, fragile, powerless and abnormal bones; the Chinese traditional treatment has the effects of nourishing liver and kidney, strengthening tendons and bones, invigorating spleen, replenishing qi, nourishing the blood and promoting blood circulation. The traditional Chinese medicine preparation for treating osteoporosis, which is disclosed by the invention, is prepared by decocting traditional Chinese medicinal materials including diversifolious osmanthus branchlet leaf and bark, poisonous buttercup fruit, polytichum commune hedw, orchis, evergreen mucuna root and leaf, Yunnan madder, dendrobium loddigesii, chinese box twig, sargentgloryvine stem and vitis flexuosa root by using water; found from clinical tests, the total effective rate achieves 95.2%; the curative effect is obvious; furthermore, patients do not have adverse effect in the treatment process.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, relate in particular to a kind of Chinese medicine preparation for the treatment of osteoporosis.
Background technology
Osteoporosis (osteoporosis syndrome) is a kind of general osteopathia, shows as bone total amount and reduces, or the minimizing of unit volume internal skeleton tissue mass, sclerotin organic principle generates not enough, and secondary calcareous infarct reduces.The bone amount of normal adult reduces with age growth, therefore old people often has physiological osteoporosis.Osteoporosis is a kind of performance of aging, if osteoporosis is with fracture, obvious lumbago and backache or nervous symptoms, should be considered as a kind of disease.Doctor trained in Western medicine, for the normal usability hormone for the treatment of of primary disease, supplement calcium and vitamin D etc., but a large amount of gonadal hormone of life-time service has obvious side effect, and the supplementary dosage of calcium and vitamin D is difficult to grasp, and curative effect is also imprecise.Recent study shows that the traditional Chinese medical science adopts this disease for the treatment of by Chinese herbs taking the kidney invigorating and essence nourishing, bone and muscle strengthening as main effect, can adjust the function of hypothalamic pituitary gonadal axis, improve the relation between hypothalamus and hypophysis, improve the level of gonadal hormone in body, thereby strengthen osteogenesis function, obtained significant curative effect.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine preparation for the treatment of osteoporosis.Osteoporosis belongs to the categories such as motherland's medical science rheumatism involving the bone, the atrophic debility of bones.The traditional Chinese medical science is thought kidney governing bones, raw marrow store essential substances, is the congenital foundation, and the prosperity and decline of kidney essense has substantial connection to the growth metabolism of skeleton.The biochemistry of the sufficient bone marrow of kidney essense is active, and bone marrow fills, and skeleton obtains the skeleton heavily fortified point of abundant nourishing of marrow.Kidney essense is lost, and bone marrow is biochemical not enough, and pulp cavity is hollow and can not nutrition skeleton, causes skeleton development bad, fragile unable, becomes raw deformity.The suitable nourishing the liver and kidney of Chinese traditional treatment, strengthening the tendons and bones, invigorating the spleen and replenishing QI, nourshing blood and promoting blood circulation.
The object of the invention is to be achieved through the following technical solutions, the Chinese medicine preparation of this treatment osteoporosis is made up of the Chinese medicine of following weight portion: Cortex Osmanthi Heterophylli 5-9 part, Fructus Ranunculi Scelerati 6-9 part, Herba Polytrichi 40-50 part, Herba Orchidis Latifoliae 9-12 part, Radix Seu Caulis Mucunae Sempervirentis 12-20 part, Radix Rubiae yunnanensis 35-45 part, Herba Dendrobii 9-15 part, Folium Vaccinii Fragilis 9-15 part, Caulis Mucunae Wangii 30-40 Fen, Radix vitis flexuosae 20-25 part.
Preferably, 7 parts of Cortex Osmanthi Heterophylli, 7.5 parts of Fructus Ranunculi Scelerati, 45 parts of Herba Polytrichis, 10 parts of Herba Orchidis Latifoliae, 16 parts of Radix Seu Caulis Mucunae Sempervirentis, 40 parts of Radix Rubiae yunnanensis, 12 parts of Herba Dendrobii, 12 parts of Folium Vaccinii Fragiliss, 23 parts of Caulis Mucunae Wangii 35 Fen, Radix vitis flexuosae.
Above-mentioned Chinese medicine decocting is made decoction by preparation method.
Fang Zhong: Cortex Osmanthi Heterophylli invigorating the liver and kidney, strong waist knee joint; Fructus Ranunculi Scelerati tonifying YIN is supported essence, cough-relieving relieving restlessness, wind-damp dispelling; Herba Polytrichi YIN nourishing arresting sweating tonify deficiency; Herba Orchidis Latifoliae enriching yin and nourishing kidney, promoting the production of body fluid to quench thirst, spleen invigorating heart tonifying; Enrich blood promoting the circulation of blood, dysmenorrhea of Radix Seu Caulis Mucunae Sempervirentis is active; Radix Rubiae yunnanensis is enriched blood and is invigorated blood circulation, expelling wind and removing dampness; Herba Dendrobii yin nourishing, heat clearing away, spleen invigorating; Folium Vaccinii Fragilis relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation and stopping pain; Caulis Mucunae Wangii relaxing muscles and tendons and activating QI and blood in the collateral, regulating menstruation; Radix vitis flexuosae nourishing qi and blood, reuniting the fractured tendons and bones, longue meat.
Clinical data
1, the routine patient of physical data 42 all meets diagnosis of osteoporosis standard, wherein male 16 examples, female's 26 examples, 45～70 years old age, average 61.6 years old, the course of disease 2 years～15 years.
2, diagnostic criteria (1) backache from asymptomatic to serious clinically.(2) vertebral body compression fracture and atrophy, and amyelia stress disorders volt; Hunchback, height shortens.(3) serum calcium, phosphorus, alkaline phosphatase enzyme level are normal.(4) bone mineral density lowers, especially vertebral body and pelvis bone.
3, this group of Therapeutic Method patient takes Chinese medicine preparation of the present invention, take Cortex Osmanthi Heterophylli 7g, Fructus Ranunculi Scelerati 7.5g, Herba Polytrichi 45g, Herba Orchidis Latifoliae 10g, Radix Seu Caulis Mucunae Sempervirentis 16g, Radix Rubiae yunnanensis 40g, Herba Dendrobii 12g, Folium Vaccinii Fragilis 12g, Caulis Mucunae Wangii 35g, Radix vitis flexuosae 23g, decocting becomes decoction, every day potion, divide and sooner or later take for 2 times, two courses for the treatment of Monday, take continuously four courses for the treatment of.
4, criterion of therapeutical effect clinical cure: tcm clinical practice symptom, sign disappear or substantially disappear; Effective: tcm clinical practice symptom, sign are obviously improved; Effective: tcm clinical practice symptom and sign all take a favorable turn; Invalid: tcm clinical practice symptom, sign are not improved, and even increase the weight of.
5, observe the curative effect after four courses for the treatment of of therapeutic outcome treatment, 42 routine patients, wherein clinical cure 19 examples (45.2%), effective 11 examples (26.2%), effective 10 examples (23.8%), invalid 2 examples (4.8%), total effective rate 95.2%, in therapeutic process there is not untoward reaction in patient.Therapeutic outcome shows that Chinese medicine preparation of the present invention has significant curative effect aspect treatment osteoporosis.
Detailed description of the invention
Embodiment mono-: take Cortex Osmanthi Heterophylli 7g, Fructus Ranunculi Scelerati 7.5g, Herba Polytrichi 45g, Herba Orchidis Latifoliae 10g, Radix Seu Caulis Mucunae Sempervirentis 16g, Radix Rubiae yunnanensis 40g, Herba Dendrobii 12g, Folium Vaccinii Fragilis 12g, Caulis Mucunae Wangii 35g, Radix vitis flexuosae 23g, above-mentioned Chinese medicine decocting is become to decoction.
Embodiment bis-: take Cortex Osmanthi Heterophylli 9g, Fructus Ranunculi Scelerati 6g, Herba Polytrichi 50g, Herba Orchidis Latifoliae 9g, Radix Seu Caulis Mucunae Sempervirentis 20g, Radix Rubiae yunnanensis 45g, Herba Dendrobii 15g, Folium Vaccinii Fragilis 9g, Caulis Mucunae Wangii 40g, Radix vitis flexuosae 25g, above-mentioned Chinese medicine decocting is become to decoction.
Embodiment tri-: take Cortex Osmanthi Heterophylli 5g, Fructus Ranunculi Scelerati 9g, Herba Polytrichi 40g, Herba Orchidis Latifoliae 12g, Radix Seu Caulis Mucunae Sempervirentis 12g, Radix Rubiae yunnanensis 35g, Herba Dendrobii 9g, Folium Vaccinii Fragilis 15g, Caulis Mucunae Wangii 30g, Radix vitis flexuosae 20g, above-mentioned Chinese medicine decocting is become to decoction.
Claims (2)
1. treat a Chinese medicine preparation for osteoporosis, it is characterized in that this Chinese medicine preparation is made up of the Chinese medicine of following weight portion: Cortex Osmanthi Heterophylli 5-9 part, Fructus Ranunculi Scelerati 6-9 part, Herba Polytrichi 40-50 part, Herba Orchidis Latifoliae 9-12 part, Radix Seu Caulis Mucunae Sempervirentis 12-20 part, Radix Rubiae yunnanensis 35-45 part, Herba Dendrobii 9-15 part, Folium Vaccinii Fragilis 9-15 part, Caulis Mucunae Wangii 30-40 part, Radix vitis flexuosae 20-25 part.
2. a kind of Chinese medicine preparation for the treatment of osteoporosis as claimed in claim 1, is characterized in that this Chinese medicine preparation is made up of the Chinese medicine of following weight portion: 7 parts of Cortex Osmanthi Heterophylli, 7.5 parts of Fructus Ranunculi Scelerati, 45 parts of Herba Polytrichis, 10 parts of Herba Orchidis Latifoliae, 16 parts of Radix Seu Caulis Mucunae Sempervirentis, 40 parts of Radix Rubiae yunnanensis, 12 parts of Herba Dendrobii, 12 parts of Folium Vaccinii Fragiliss, 23 parts of Caulis Mucunae Wangii 35 Fen, Radix vitis flexuosae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410106278.7A CN103860905A (en) | 2014-03-14 | 2014-03-14 | Traditional Chinese medicine preparation for treating osteoporosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410106278.7A CN103860905A (en) | 2014-03-14 | 2014-03-14 | Traditional Chinese medicine preparation for treating osteoporosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103860905A true CN103860905A (en) | 2014-06-18 |
Family
ID=50900292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410106278.7A Pending CN103860905A (en) | 2014-03-14 | 2014-03-14 | Traditional Chinese medicine preparation for treating osteoporosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103860905A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104435230A (en) * | 2014-12-19 | 2015-03-25 | 鹿泽兵 | Medicine for treating osteoporosis and preparation method of medicine |
| CN105250607A (en) * | 2015-10-15 | 2016-01-20 | 张凯 | Chinese herb preparation for treating osteoporosis and nursing method |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101953993A (en) * | 2010-08-27 | 2011-01-26 | 高燕 | Medicament for treating osteoporosis |
| CN102935145A (en) * | 2012-11-27 | 2013-02-20 | 张晨 | Chinese medicinal preparation for treating osteoporosis |
| CN103125930A (en) * | 2011-12-01 | 2013-06-05 | 鲜丹科 | Muscle and bone tonifying bean |
| CN103131605A (en) * | 2011-12-01 | 2013-06-05 | 鲜丹科 | Muscle and bone wine |
| CN103330837A (en) * | 2013-07-17 | 2013-10-02 | 王磊 | Traditional Chinese medicine composition for curing osteoporosis of menopausal women |
-
2014
- 2014-03-14 CN CN201410106278.7A patent/CN103860905A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101953993A (en) * | 2010-08-27 | 2011-01-26 | 高燕 | Medicament for treating osteoporosis |
| CN103125930A (en) * | 2011-12-01 | 2013-06-05 | 鲜丹科 | Muscle and bone tonifying bean |
| CN103131605A (en) * | 2011-12-01 | 2013-06-05 | 鲜丹科 | Muscle and bone wine |
| CN102935145A (en) * | 2012-11-27 | 2013-02-20 | 张晨 | Chinese medicinal preparation for treating osteoporosis |
| CN103330837A (en) * | 2013-07-17 | 2013-10-02 | 王磊 | Traditional Chinese medicine composition for curing osteoporosis of menopausal women |
Non-Patent Citations (2)
| Title |
|---|
| 傅刚等: "增骨I、Ⅱ、Ⅲ号对体外培养成骨细胞影响的实验研究", 《中国中西医结合杂志》 * |
| 苏颖燕: "中彝医结合治疗桡骨远端骨折的护理", 《云南中医中药杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104435230A (en) * | 2014-12-19 | 2015-03-25 | 鹿泽兵 | Medicine for treating osteoporosis and preparation method of medicine |
| CN105250607A (en) * | 2015-10-15 | 2016-01-20 | 张凯 | Chinese herb preparation for treating osteoporosis and nursing method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102078482B (en) | Traditional Chinese medicine combination for treating bone injury and fracture and preparation method of the same | |
| CN103142811A (en) | Traditional Chinese medicine for treating primary osteoporosis | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN103800489A (en) | Traditional Chinese medicine wine for treating cervical spondylosis and preparation method of traditional Chinese medicine wine | |
| CN103860905A (en) | Traditional Chinese medicine preparation for treating osteoporosis | |
| CN103006980B (en) | Chinese medicinal composition for treating distention and fullness | |
| CN102106979B (en) | Medicament for treating hypertension | |
| CN105311420A (en) | Traditional Chinese medicine composition for treating stroke and sequelae thereof | |
| CN114767735A (en) | Chinese medicinal prescription for invigorating spleen and kidney and its product for improving sarcopenia and muscular atrophy after fracture | |
| CN103720847A (en) | Formula of hyperosteogeny treatment emplastrum | |
| CN103585414B (en) | Pharmaceutical composition for treating sciatica and osteoporosis | |
| CN102114070A (en) | Compound traditional Chinese medicine for treating osteoporosis and preparation method thereof | |
| CN105250809A (en) | Traditional Chinese medicine composition for treating dermatomyositis | |
| CN100363036C (en) | Chinese medicine composition for treating diabets and preparing method | |
| CN1087619C (en) | Medicines for treating osteoporosis and their preparing process | |
| CN109876084A (en) | A kind of pharmaceutical composition for treating caput femoris necrosis | |
| CN103272029A (en) | Traditional Chinese medicine formula for curing hypertension | |
| CN103191315A (en) | Traditional Chinese medicine for treating postmenopausal osteoporosis | |
| CN103285108B (en) | Chinese medicinal composition treating lumbago | |
| CN105853668A (en) | Medicament for treating lumbar disc herniation, osteoporosis and cervical spondylosis | |
| CN1498629A (en) | Chinese traditional medicine for treating osteoporosis and its prepn. method | |
| CN105192833A (en) | Health drink and preparation method thereof | |
| CN105998257A (en) | Formula of traditional Chinese medicine for treating lumbar vertebrae bone hyperplasia | |
| CN105616704A (en) | Traditional Chinese medicine preparation for sclerotin healing of osteoporotic fracture | |
| CN104826095A (en) | Chondroitin co-produced protein powder as well as production method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140618 |
|
| RJ01 | Rejection of invention patent application after publication |